Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial
- 1 December 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9195), 2019-2024
- https://doi.org/10.1016/s0140-6736(99)10018-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Minimal myocardial damage during coronary intervention is associated with impaired outcomeEuropean Heart Journal, 1999
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Coronary-Artery Stents — Gauging, Gorging, and GougingNew England Journal of Medicine, 1998
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel DiseaseNew England Journal of Medicine, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Subacute stent thrombosis: Evolving issues and current conceptsJournal of the American College of Cardiology, 1996
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1993